{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T13:56:37Z","timestamp":1774360597323,"version":"3.50.1"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Natural Science Foundation of Sichuan Province","award":["2024NSFSC1709"],"award-info":[{"award-number":["2024NSFSC1709"]}]},{"name":"The Scientific Research Project of The Third People\u2019s Hospital of Chengdu","award":["CSY-YN-01-2023-041, CSY-YN-03-2024-018"],"award-info":[{"award-number":["CSY-YN-01-2023-041, CSY-YN-03-2024-018"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-026-05599-x","type":"journal-article","created":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T11:37:33Z","timestamp":1771241853000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The role of inflammation and coronary artery lesion severity in patients undergoing percutaneous coronary intervention: a retrospective cohort study"],"prefix":"10.1186","volume":"26","author":[{"given":"Maoling","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiao","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongyue","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Long","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanxiong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiqiang","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,16]]},"reference":[{"issue":"8","key":"5599_CR1","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41573-021-00198-1","volume":"20","author":"O Soehnlein","year":"2021","unstructured":"Soehnlein O, Libby P. Targeting inflammation in atherosclerosis - from experimental insights to the clinic. Nat Rev Drug Discov. 2021;20(8):589\u2013610.","journal-title":"Nat Rev Drug Discov"},{"issue":"7855","key":"5599_CR2","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s41586-021-03392-8","volume":"592","author":"P Libby","year":"2021","unstructured":"Libby P. The changing landscape of atherosclerosis. Nature. 2021;592(7855):524\u201333.","journal-title":"Nature"},{"issue":"4","key":"5599_CR3","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.tcm.2021.04.002","volume":"32","author":"GE Shaya","year":"2022","unstructured":"Shaya GE, Leucker TM, Jones SR, Martin SS, Toth PP. Coronary heart disease risk: Low-density lipoprotein and beyond. Trends Cardiovasc Med. 2022;32(4):181\u201394.","journal-title":"Trends Cardiovasc Med"},{"key":"5599_CR4","doi-asserted-by":"publisher","first-page":"176338","DOI":"10.1016\/j.ejphar.2024.176338","volume":"966","author":"A Attiq","year":"2024","unstructured":"Attiq A, Afzal S, Ahmad W, Kandeel M. Hegemony of inflammation in atherosclerosis and coronary artery disease. Eur J Pharmacol. 2024;966:176338.","journal-title":"Eur J Pharmacol"},{"key":"5599_CR5","doi-asserted-by":"crossref","unstructured":"Ruparelia N, Choudhury R. Inflammation and atherosclerosis: what is on the horizon? Heart. 2020;106(1):80\u20135.","DOI":"10.1136\/heartjnl-2018-314230"},{"issue":"6","key":"5599_CR6","doi-asserted-by":"publisher","first-page":"e101282","DOI":"10.1136\/gpsych-2023-101282","volume":"36","author":"HT Ong","year":"2023","unstructured":"Ong HT, Chen J. Mental stress, atheroma, myocardial ischaemia and injury: the link is inflammation. Gen Psychiatr. 2023;36(6):e101282.","journal-title":"Gen Psychiatr"},{"issue":"3","key":"5599_CR7","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.jcin.2023.12.004","volume":"17","author":"M Vinayak","year":"2024","unstructured":"Vinayak M, Cao D, Tanner R, Koshy AN, Farhan S, Vogel B, Sartori S, Feng Y, Dhulipala V, Arora A, et al. Impact of bleeding risk and inflammation on cardiovascular outcomes after percutaneous coronary intervention. JACC Cardiovasc Interv. 2024;17(3):345\u201355.","journal-title":"JACC Cardiovasc Interv"},{"key":"5599_CR8","doi-asserted-by":"publisher","first-page":"119242","DOI":"10.1016\/j.atherosclerosis.2025.119242","volume":"406","author":"J Fledderus","year":"2025","unstructured":"Fledderus J, Vanchin B, Brouwer L, Kuiper T, Jongman RM, van Meurs M, Harmsen MC, Krenning G. H3K27Me3 abundance is associated with a decreased barrier function of endothelial cells by directly Silencing VE-cadherin expression. Atherosclerosis. 2025;406:119242.","journal-title":"Atherosclerosis"},{"key":"5599_CR9","doi-asserted-by":"crossref","unstructured":"Nicolau AM, Silva PG, Mej\u00eda HPG, Granada JF, Kaluza GL, Burkhoff D, Abizaid T, Pileggi B, Freire AFD, Godinho RR, et al. Molecular mechanisms of microvascular obstruction and dysfunction in percutaneous coronary interventions: from pathophysiology to Therapeutics-A comprehensive review. Int J Mol Sci. 2025;26(14):6835.","DOI":"10.3390\/ijms26146835"},{"issue":"6","key":"5599_CR10","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1093\/cvr\/cvx049","volume":"113","author":"DJ Hausenloy","year":"2017","unstructured":"Hausenloy DJ, Garcia-Dorado D, B\u00f8tker HE, Davidson SM, Downey J, Engel FB, Jennings R, Lecour S, Leor J, Madonna R, et al. Novel targets and future strategies for acute cardioprotection: position paper of the European society of cardiology working group on cellular biology of the heart. Cardiovasc Res. 2017;113(6):564\u201385.","journal-title":"Cardiovasc Res"},{"issue":"12","key":"5599_CR11","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/s41569-020-0403-y","volume":"17","author":"G Heusch","year":"2020","unstructured":"Heusch G. Myocardial ischaemia-reperfusion injury and cardioprotection in perspective. Nat Rev Cardiol. 2020;17(12):773\u201389.","journal-title":"Nat Rev Cardiol"},{"key":"5599_CR12","doi-asserted-by":"publisher","first-page":"1618242","DOI":"10.3389\/fcvm.2025.1618242","volume":"12","author":"J BoYuan","year":"2025","unstructured":"BoYuan J, TingTing W, ChengJun H, XinYi H, YuShan C. Coronary microcirculatory dysfunction after percutaneous coronary intervention: pathogenesis, diagnosis, and therapeutic strategies. Front Cardiovasc Med. 2025;12:1618242.","journal-title":"Front Cardiovasc Med"},{"key":"5599_CR13","doi-asserted-by":"crossref","unstructured":"Tucker B, Vaidya K, Cochran BJ, Patel S. Inflammation during percutaneous coronary Intervention-Prognostic Value, mechanisms and therapeutic targets. Cells. 2021;10(6):1391.","DOI":"10.3390\/cells10061391"},{"issue":"9","key":"5599_CR14","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1093\/eurheartj\/ehaa1034","volume":"42","author":"NH Adamstein","year":"2021","unstructured":"Adamstein NH, MacFadyen JG, Rose LM, Glynn RJ, Dey AK, Libby P, Tabas IA, Mehta NN, Ridker PM. The neutrophil-lymphocyte ratio and incident atherosclerotic events: analyses from five contemporary randomized trials. Eur Heart J. 2021;42(9):896\u2013903.","journal-title":"Eur Heart J"},{"issue":"26","key":"5599_CR15","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","volume":"381","author":"JC Tardif","year":"2019","unstructured":"Tardif JC, Kouz S, Waters DD, Bertrand OF, Diaz R, Maggioni AP, Pinto FJ, Ibrahim R, Gamra H, Kiwan GS, et al. Efficacy and safety of Low-Dose Colchicine after myocardial infarction. N Engl J Med. 2019;381(26):2497\u2013505.","journal-title":"N Engl J Med"},{"issue":"19","key":"5599_CR16","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1056\/NEJMoa2021372","volume":"383","author":"SM Nidorf","year":"2020","unstructured":"Nidorf SM, Fiolet ATL, Mosterd A, Eikelboom JW, Schut A, Opstal TSJ, The SHK, Xu XF, Ireland MA, Lenderink T, et al. Colchicine in patients with chronic coronary disease. N Engl J Med. 2020;383(19):1838\u201347.","journal-title":"N Engl J Med"},{"issue":"23","key":"5599_CR17","doi-asserted-by":"publisher","first-page":"8334","DOI":"10.3390\/jcm14238334","volume":"14","author":"I Forzano","year":"2025","unstructured":"Forzano I, Florimonte D, Narciso V, Canonico ME, Castiello DS, Manzi L, Cristiano S, Spinelli A, Vallone DM, D\u2019Alconzo D, et al. Optimal medical therapy targeting lipids and inflammation for secondary prevention in patients undergoing percutaneous coronary intervention. J Clin Med. 2025;14(23):8334.","journal-title":"J Clin Med"},{"key":"5599_CR18","doi-asserted-by":"crossref","unstructured":"Tsalamandris S, Koliastasis L, Miliou A, Oikonomou E, Papageorgiou N, Antonopoulos A, Hatzis G, Mourouzis K, Vogiatzi G, Siasos G, et al. Endothelial function and Pro-Inflammatory cytokines as prognostic markers in acute coronary syndromes. Diagnostics (Basel). 2025;15(8):1033.","DOI":"10.3390\/diagnostics15081033"},{"key":"5599_CR19","doi-asserted-by":"publisher","first-page":"e2580","DOI":"10.6061\/clinics\/2021\/e2580","volume":"76","author":"J Sheng","year":"2021","unstructured":"Sheng J, Liu N, He F, Cheng C, Shen S, Sun Y. Changes in the neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios before and after percutaneous coronary intervention and their impact on the prognosis of patients with acute coronary syndrome. Clin (Sao Paulo). 2021;76:e2580.","journal-title":"Clin (Sao Paulo)"},{"issue":"6","key":"5599_CR20","doi-asserted-by":"publisher","first-page":"dju124","DOI":"10.1093\/jnci\/dju124","volume":"106","author":"AJ Templeton","year":"2014","unstructured":"Templeton AJ, McNamara MG, \u0160eruga B, Vera-Badillo FE, Aneja P, Oca\u00f1a A, Leibowitz-Amit R, Sonpavde G, Knox JJ, Tran B, et al. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst. 2014;106(6):dju124.","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"5599_CR21","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1177\/1076029613499821","volume":"20","author":"H Kaya","year":"2014","unstructured":"Kaya H, Erta\u015f F, Soydin\u00e7 MS. Association between neutrophil to lymphocyte ratio and severity of coronary artery disease. Clin Appl Thromb Hemost. 2014;20(2):221.","journal-title":"Clin Appl Thromb Hemost"},{"key":"5599_CR22","doi-asserted-by":"crossref","unstructured":"Tudurachi BS, Anghel L, Tudurachi A, Sasc\u0103u RA, St\u0103tescu C. Assessment of inflammatory hematological ratios (NLR, PLR, MLR, LMR and Monocyte\/HDL-Cholesterol Ratio) in acute myocardial infarction and particularities in young patients. Int J Mol Sci. 2023;24(18):14378.","DOI":"10.3390\/ijms241814378"},{"key":"5599_CR23","doi-asserted-by":"crossref","unstructured":"Xia Y, Xia C, Wu L, Li Z, Li H, Zhang J. Systemic immune inflammation index (SII), system inflammation response index (SIRI) and risk of All-Cause mortality and cardiovascular mortality: A 20-Year Follow-Up cohort study of 42,875 US adults. J Clin Med. 2023;12(3):1128.","DOI":"10.3390\/jcm12031128"},{"issue":"6","key":"5599_CR24","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/s41569-019-0326-7","volume":"17","author":"C Silvestre-Roig","year":"2020","unstructured":"Silvestre-Roig C, Braster Q, Ortega-Gomez A, Soehnlein O. Neutrophils as regulators of cardiovascular inflammation. Nat Rev Cardiol. 2020;17(6):327\u201340.","journal-title":"Nat Rev Cardiol"},{"issue":"4","key":"5599_CR25","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1161\/CIRCRESAHA.115.306301","volume":"118","author":"MA Gimbrone Jr","year":"2016","unstructured":"Gimbrone MA Jr., Garc\u00eda-Carde\u00f1a G. Endothelial cell dysfunction and the pathobiology of atherosclerosis. Circ Res. 2016;118(4):620\u201336.","journal-title":"Circ Res"},{"issue":"6","key":"5599_CR26","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1001\/jamacardio.2018.1042","volume":"3","author":"S Kim","year":"2018","unstructured":"Kim S, Eliot M, Koestler DC, Wu WC, Kelsey KT. Association of Neutrophil-to-Lymphocyte ratio with mortality and cardiovascular disease in the Jackson heart study and modification by the Duffy antigen variant. JAMA Cardiol. 2018;3(6):455\u201362.","journal-title":"JAMA Cardiol"},{"key":"5599_CR27","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.atherosclerosis.2018.05.022","volume":"274","author":"GP Machado","year":"2018","unstructured":"Machado GP, Araujo GN, Carpes CK, Lech M, Mariani S, Valle FH, Bergoli LCC, Gon\u00e7alves SC, Wainstein RV, Wainstein MV. Comparison of neutrophil-to-lymphocyte ratio and mean platelet volume in the prediction of adverse events after primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction. Atherosclerosis. 2018;274:212\u20137.","journal-title":"Atherosclerosis"},{"issue":"2","key":"5599_CR28","doi-asserted-by":"publisher","first-page":"e0296838","DOI":"10.1371\/journal.pone.0296838","volume":"19","author":"Y Wang","year":"2024","unstructured":"Wang Y, Zhuang Y, Lin C, Hong H, Chen F, Ke J. The neutrophil-to-lymphocyte ratio is associated with coronary heart disease risk in adults: A population-based study. PLoS ONE. 2024;19(2):e0296838.","journal-title":"PLoS ONE"},{"issue":"7","key":"5599_CR29","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1093\/eurjpc\/zwae007","volume":"31","author":"DM Leistner","year":"2024","unstructured":"Leistner DM, Laguna-Fernandez A, Haghikia A, Abdelwahed YS, Schatz AS, Erbay A, Roehle R, Fonseca AF, Ferber P, Landmesser U. Impact of elevated lipoprotein(a) on coronary artery disease phenotype and severity. Eur J Prev Cardiol. 2024;31(7):856\u201365.","journal-title":"Eur J Prev Cardiol"},{"issue":"37","key":"5599_CR30","doi-asserted-by":"publisher","first-page":"2530","DOI":"10.1093\/eurheartj\/ehu074","volume":"35","author":"GG Stefanini","year":"2014","unstructured":"Stefanini GG, Stortecky S, Cao D, Rat-Wirtzler J, O\u2019Sullivan CJ, Gloekler S, Buellesfeld L, Khattab AA, Nietlispach F, Pilgrim T, et al. Coronary artery disease severity and aortic stenosis: clinical outcomes according to SYNTAX score in patients undergoing transcatheter aortic valve implantation. Eur Heart J. 2014;35(37):2530\u201340.","journal-title":"Eur Heart J"},{"issue":"4","key":"5599_CR31","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1161\/CIRCINTERVENTIONS.109.914051","volume":"3","author":"S Garg","year":"2010","unstructured":"Garg S, Sarno G, Garcia-Garcia HM, Girasis C, Wykrzykowska J, Dawkins KD, Serruys PW. A new tool for the risk stratification of patients with complex coronary artery disease: the clinical SYNTAX score. Circ Cardiovasc Interv. 2010;3(4):317\u201326.","journal-title":"Circ Cardiovasc Interv"},{"issue":"9","key":"5599_CR32","first-page":"680","volume":"46","author":"[Guideline on the","year":"2018","unstructured":"[Guideline on the. Diagnosis and treatment of stable coronary artery disease]. Zhonghua Xin Xue Guan Bing Za Zhi. 2018;46(9):680\u201394.","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"issue":"2","key":"5599_CR33","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1093\/eurheartj\/ehy394","volume":"40","author":"FJ Neumann","year":"2019","unstructured":"Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, Byrne RA, Collet JP, Falk V, Head SJ, et al. : 2018 ESC\/EACTS guidelines on myocardial revascularization. Eur Heart J. 2019;40(2):87\u2013165.","journal-title":"Eur Heart J"},{"issue":"5","key":"5599_CR34","first-page":"382","volume":"44","author":"[Chinese guideline for percutaneous coronary","year":"2016","unstructured":"[Chinese guideline for percutaneous coronary. intervention(2016)]. Zhonghua Xin Xue Guan Bing Za Zhi. 2016;44(5):382\u2013400.","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"issue":"3","key":"5599_CR35","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1093\/eurheartj\/ehv320","volume":"37","author":"M Roffi","year":"2016","unstructured":"Roffi M, Patrono C, Collet JP, Mueller C, Valgimigli M, Andreotti F, Bax JJ, Borger MA, Brotons C, Chew DP, et al. 2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: task force for the management of acute coronary syndromes in patients presenting without persistent ST-Segment elevation of the European society of cardiology (ESC). Eur Heart J. 2016;37(3):267\u2013315.","journal-title":"Eur Heart J"},{"issue":"12","key":"5599_CR36","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.recesp.2017.10.048","volume":"70","author":"B Ib\u00e1nez","year":"2017","unstructured":"Ib\u00e1nez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, Caforio ALP, Crea F, Goudevenos JA, Halvorsen S, et al. 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Rev Esp Cardiol (Engl Ed). 2017;70(12):1082.","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"issue":"38","key":"5599_CR37","doi-asserted-by":"publisher","first-page":"3912","DOI":"10.1093\/eurheartj\/ehae178","volume":"45","author":"JW McEvoy","year":"2024","unstructured":"McEvoy JW, McCarthy CP, Bruno RM, Brouwers S, Canavan MD, Ceconi C, Christodorescu RM, Daskalopoulou SS, Ferro CJ, Gerdts E, et al. 2024 ESC guidelines for the management of elevated blood pressure and hypertension. Eur Heart J. 2024;45(38):3912\u20134018.","journal-title":"Eur Heart J"},{"issue":"Suppl 1","key":"5599_CR38","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.2337\/dc23-S002","volume":"46","author":"NA ElSayed","year":"2023","unstructured":"ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, Collins BS, Hilliard ME, Isaacs D, Johnson EL, et al. 2. Classification and diagnosis of diabetes: standards of care in Diabetes-2023. Diabetes Care. 2023;46(Suppl 1):S19\u201340.","journal-title":"Diabetes Care"},{"issue":"1","key":"5599_CR39","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s12933-024-02276-1","volume":"23","author":"Q Chen","year":"2024","unstructured":"Chen Q, Xiong S, Ye T, Gao Y, Wang J, Li X, Li Y, Cui C, Liu H, Zhang Z, et al. Insulin resistance, coronary artery lesion complexity and adverse cardiovascular outcomes in patients with acute coronary syndrome. Cardiovasc Diabetol. 2024;23(1):172.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"5599_CR40","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41392-022-00955-7","volume":"7","author":"P Kong","year":"2022","unstructured":"Kong P, Cui ZY, Huang XF, Zhang DD, Guo RJ, Han M. Inflammation and atherosclerosis: signaling pathways and therapeutic intervention. Signal Transduct Target Ther. 2022;7(1):131.","journal-title":"Signal Transduct Target Ther"},{"key":"5599_CR41","doi-asserted-by":"crossref","unstructured":"Tasouli-Drakou V, Ogurek I, Shaikh T, Ringor M, DiCaro MV, Lei K. Atherosclerosis: A comprehensive review of molecular factors and mechanisms. Int J Mol Sci. 2025;26(3):1364.","DOI":"10.3390\/ijms26031364"},{"issue":"10","key":"5599_CR42","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1016\/j.jacc.2005.02.054","volume":"45","author":"BD Horne","year":"2005","unstructured":"Horne BD, Anderson JL, John JM, Weaver A, Bair TL, Jensen KR, Renlund DG, Muhlestein JB. Which white blood cell subtypes predict increased cardiovascular risk? J Am Coll Cardiol. 2005;45(10):1638\u201343.","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"5599_CR43","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.amjcard.2007.11.004","volume":"101","author":"J N\u00fa\u00f1ez","year":"2008","unstructured":"N\u00fa\u00f1ez J, N\u00fa\u00f1ez E, Bod\u00ed V, Sanchis J, Mi\u00f1ana G, Mainar L, Santas E, Merlos P, Rumiz E, Darmofal H, et al. Usefulness of the neutrophil to lymphocyte ratio in predicting long-term mortality in ST segment elevation myocardial infarction. Am J Cardiol. 2008;101(6):747\u201352.","journal-title":"Am J Cardiol"},{"key":"5599_CR44","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.carrev.2023.09.003","volume":"60","author":"ET Ha","year":"2024","unstructured":"Ha ET, Yee A, Peterson SJ, Kobayashi Y, Sacchi T, Parikh M, Brener SJ. Neutrophil-to-lymphocyte ratio and prognosis in patients undergoing percutaneous coronary intervention for acute coronary syndrome. Cardiovasc Revasc Med. 2024;60:29\u201334.","journal-title":"Cardiovasc Revasc Med"},{"key":"5599_CR45","doi-asserted-by":"publisher","first-page":"1502964","DOI":"10.3389\/fcvm.2025.1502964","volume":"12","author":"Y Li","year":"2025","unstructured":"Li Y, Chen D, Fan Y, Zhu Q, Deng H, Chai X. Association between neutrophil to lymphocyte ratio and all-cause mortality in critical patients with coronary artery disease - a study based on the MIMIC-IV database. Front Cardiovasc Med. 2025;12:1502964.","journal-title":"Front Cardiovasc Med"},{"issue":"26","key":"5599_CR46","doi-asserted-by":"publisher","first-page":"e38692","DOI":"10.1097\/MD.0000000000038692","volume":"103","author":"H Ul Hussain","year":"2024","unstructured":"Ul Hussain H, Kumar KA, Zahid M, Husban Burney M, Khan Z, Asif M, Rehan ST, Ahmad Cheema H, Swed S, Yasmin F, et al. Neutrophil to lymphocyte ratio as a prognostic marker for cardiovascular outcomes in patients with ST-segment elevation myocardial infarction after percutaneous coronary intervention: A systematic review and meta-analysis. Med (Baltim). 2024;103(26):e38692.","journal-title":"Med (Baltim)"},{"issue":"1","key":"5599_CR47","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1161\/CIRCRESAHA.121.319822","volume":"130","author":"AC Doran","year":"2022","unstructured":"Doran AC. Inflammation resolution: implications for atherosclerosis. Circ Res. 2022;130(1):130\u201348.","journal-title":"Circ Res"},{"key":"5599_CR48","doi-asserted-by":"crossref","unstructured":"Singh P, Kumar N, Singh M, Kaur M, Singh G, Narang A, Kanwal A, Sharma K, Singh B, Napoli MD, et al. Neutrophil extracellular traps and NLRP3 inflammasome: A disturbing duo in Atherosclerosis, inflammation and atherothrombosis. Vaccines (Basel). 2023;11(2):261.","DOI":"10.3390\/vaccines11020261"},{"issue":"2","key":"5599_CR49","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1161\/CIRCRESAHA.118.313591","volume":"124","author":"D Wolf","year":"2019","unstructured":"Wolf D, Ley K. Immunity and inflammation in atherosclerosis. Circ Res. 2019;124(2):315\u201327.","journal-title":"Circ Res"},{"issue":"9","key":"5599_CR50","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1161\/CIRCRESAHA.119.315939","volume":"126","author":"I Tabas","year":"2020","unstructured":"Tabas I, Bornfeldt KE. Intracellular and intercellular aspects of macrophage immunometabolism in atherosclerosis. Circ Res. 2020;126(9):1209\u201327.","journal-title":"Circ Res"},{"key":"5599_CR51","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.atherosclerosis.2019.06.919","volume":"288","author":"IC Moschonas","year":"2019","unstructured":"Moschonas IC, Tselepis AD. The pathway of neutrophil extracellular traps towards atherosclerosis and thrombosis. Atherosclerosis. 2019;288:9\u201316.","journal-title":"Atherosclerosis"},{"key":"5599_CR52","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.atherosclerosis.2021.01.012","volume":"320","author":"R Klingenberg","year":"2021","unstructured":"Klingenberg R, Aghlmandi S, Gencer B, Nanchen D, R\u00e4ber L, Carballo D, Carballo S, St\u00e4hli BE, Landmesser U, Rodondi N, et al. Residual inflammatory risk at 12 months after acute coronary syndromes is frequent and associated with combined adverse events. Atherosclerosis. 2021;320:31\u20137.","journal-title":"Atherosclerosis"},{"key":"5599_CR53","doi-asserted-by":"crossref","unstructured":"Kraler S, Mueller C, Libby P, Bhatt DL. Acute coronary syndromes: mechanisms, challenges, and new opportunities. Eur Heart J. 2025;46(29):2866\u201389.","DOI":"10.1093\/eurheartj\/ehaf289"},{"key":"5599_CR54","doi-asserted-by":"crossref","unstructured":"Di Muro FM, Sartori S, Vogel B, Lupo S, Oliva A, Gitto M, Krishnan P, Bay B, Smith K, Sweeny J, et al. Prognostic impact of neutrophil-to-lymphocyte ratio in patients with and without diabetes mellitus undergoing percutaneous coronary intervention. Heart. 2025;111(20):960\u20138.","DOI":"10.1136\/heartjnl-2024-325396"},{"issue":"8","key":"5599_CR55","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1038\/s41440-024-01731-6","volume":"47","author":"BG Shokoples","year":"2024","unstructured":"Shokoples BG, Paradis P, Schiffrin EL. Immunological insights into hypertension: unraveling triggers and potential therapeutic avenues. Hypertens Res. 2024;47(8):2115\u201325.","journal-title":"Hypertens Res"},{"issue":"1","key":"5599_CR56","doi-asserted-by":"publisher","first-page":"e13487","DOI":"10.1111\/apha.13487","volume":"231","author":"RM Zhang","year":"2021","unstructured":"Zhang RM, McNerney KP, Riek AE, Bernal-Mizrachi C. Immunity and hypertension. Acta Physiol (Oxf). 2021;231(1):e13487.","journal-title":"Acta Physiol (Oxf)"},{"issue":"10206","key":"5599_CR57","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1016\/S0140-6736(19)31997-X","volume":"394","author":"D Thuijs","year":"2019","unstructured":"Thuijs D, Kappetein AP, Serruys PW, Mohr FW, Morice MC, Mack MJ, Holmes DR Jr., Curzen N, Davierwala P, Noack T, et al. Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial. Lancet. 2019;394(10206):1325\u201334.","journal-title":"Lancet"},{"issue":"9867","key":"5599_CR58","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(13)60141-5","volume":"381","author":"FW Mohr","year":"2013","unstructured":"Mohr FW, Morice MC, Kappetein AP, Feldman TE, St\u00e5hle E, Colombo A, Mack MJ, Holmes DR Jr., Morel MA, Van Dyck N, et al. Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial. Lancet. 2013;381(9867):629\u201338.","journal-title":"Lancet"},{"issue":"15","key":"5599_CR59","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1177\/15353702231184217","volume":"248","author":"C Gu","year":"2023","unstructured":"Gu C, Pang B, Sun S, An C, Wu M, Wang N, Yuan Y, Liu G. Neutrophil extracellular traps contributing to atherosclerosis: from pathophysiology to clinical implications. Exp Biol Med (Maywood). 2023;248(15):1302\u201312.","journal-title":"Exp Biol Med (Maywood)"},{"issue":"4","key":"5599_CR60","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/s41590-022-01165-7","volume":"23","author":"MJ Schloss","year":"2022","unstructured":"Schloss MJ, Hulsmans M, Rohde D, Lee IH, Severe N, Foy BH, Pulous FE, Zhang S, Kokkaliaris KD, Frodermann V, et al. B lymphocyte-derived acetylcholine limits steady-state and emergency hematopoiesis. Nat Immunol. 2022;23(4):605\u201318.","journal-title":"Nat Immunol"},{"issue":"13","key":"5599_CR61","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1161\/CIRCULATIONAHA.119.043833","volume":"141","author":"G Sreejit","year":"2020","unstructured":"Sreejit G, Abdel-Latif A, Athmanathan B, Annabathula R, Dhyani A, Noothi SK, Quaife-Ryan GA, Al-Sharea A, Pernes G, Dragoljevic D, et al. Neutrophil-Derived S100A8\/A9 amplify granulopoiesis after myocardial infarction. Circulation. 2020;141(13):1080\u201394.","journal-title":"Circulation"},{"issue":"2","key":"5599_CR62","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1097\/CRD.0000000000000428","volume":"31","author":"B Eghtedari","year":"2023","unstructured":"Eghtedari B, Roy SK, Budoff MJ. Anti-inflammatory therapeutics and coronary artery disease. Cardiol Rev. 2023;31(2):80\u20136.","journal-title":"Cardiol Rev"},{"issue":"12","key":"5599_CR63","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","volume":"377","author":"PM Ridker","year":"2017","unstructured":"Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, Fonseca F, Nicolau J, Koenig W, Anker SD, et al. Antiinflammatory therapy with Canakinumab for atherosclerotic disease. N Engl J Med. 2017;377(12):1119\u201331.","journal-title":"N Engl J Med"},{"issue":"09","key":"5599_CR64","first-page":"951","volume":"92","author":"TAMERM ABU ARAB MD","year":"2024","unstructured":"ABU ARAB MD TAMERM, MOHAMED YASSER A. ABDELLATIF MD: Short-Term clinical outcomes of complex percutaneous coronary intervention in patients declined for coronary artery bypass grafting: A contemporary Real-World registry. Med J Cairo Univ. 2024;92(09):951\u201361.","journal-title":"Med J Cairo Univ"},{"issue":"18","key":"5599_CR65","doi-asserted-by":"publisher","first-page":"e1051","DOI":"10.4244\/EIJ-D-24-00992","volume":"21","author":"DS Castiello","year":"2025","unstructured":"Castiello DS, Oliva A, And\u00f2 G, Niccoli G, Pelliccia F, Moscarella E, Montone RA, Gragnano F, Porto I, Calabr\u00f2 P, et al. Antithrombotic therapy in complex percutaneous coronary intervention. EuroIntervention. 2025;21(18):e1051\u201368.","journal-title":"EuroIntervention"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-026-05599-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-05599-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-05599-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T13:03:21Z","timestamp":1774357401000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12872-026-05599-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,16]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5599"],"URL":"https:\/\/doi.org\/10.1186\/s12872-026-05599-x","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,16]]},"assertion":[{"value":"13 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the medical ethics committee of the Third People\u2019s Hospital of Chengdu and strictly adhered to the Declaration of Helsinki. The ethics approval number: 2022-S-34.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"244"}}